Everpure, Inc.: Barclays cuts target price to $115 from $132
P•Barclays cut its target price for Everpure to $115 from $132.
Related News

CSPC Pharmaceutical receives US$15 million milestone payment under Corbus license deal
CRBP•

Sterling drops from 20-month high versus euro
TLT•

Lowe's investor day in focus as brokerages look for a 2027 blueprint
LOW•

Annuity rates hit 20-year high of 8.03%, Standard Life says
TLT•

New York coffee may retest resistance at $2.8920
USO•